Mechanisms of the Inhibitory Action of Neurotransmitters on Smooth Muscles

Nonadrenergic inhibitory and excitatory junction potentials (IJP and EJP) in the intestinal smooth muscle cells are of a complex transmitter and ion nature. The IJP consist of two components; the initial, fast, component is of a purinergic nature. Low-conductance Ca²⁺-dependent potassium channels (SK_(Ca)) are involved in generation of the initial component of IJP because this component can be specifically and reversibly blocked by apamin. Probably, local Ca²⁺ release from the InsP₃-sensitive store can be a link between the P2Y receptors and activation of the SK_(Ca) channels because inhibition of the activity of phospholipase C (PLC) decreases IJP. The second, slow, component of IJP is nitric oxide-dependent. Such a component of IJP develops due to activation of high-conductance Ca²⁺-dependent potassium channels (BK_(Ca)) because this component can be blocked by TEA and charybdotoxin. The release of Ca²⁺ from the ryanodine-sensitive store is responsible for activation of the BK_(Ca) channels and generation of the second component of IJP. Thus, it appears that Ca²⁺ released from one of the intracellular stores can activate only a certain type of the Ca²⁺-dependent K⁺ channels involved in the generation of IJP.     

Involvement of Secondary Intracellular Messengers in the Mechanisms of Purinergic Inhibition of Intestinal Smooth Muscles

We studied the role of adenylate cyclase and phospholipase C in the control of ATP-induced relaxation of carbachol-evoked contraction of smooth muscles of the guinea-pig taenia coli. We showed that ATP-induced relaxation of carbachol-caused contraction is completely realized under control conditions via activation of inositol trisphosphate-sensitive (InsP₃) receptors of the sarcoplasmic reticulum of smooth muscle cells (SMCs). In the case where phospholipase C was blocked, the relaxing action of ATP on smooth muscles continues to be mediated mostly by activation of InsP₃ receptors, but other mechanisms begin to participate in this process. Intracellular processes are also involved in ATP-induced relaxation where the signal is transferred from purine receptors via activation of phospholipase C under conditions of parallel activation of adenylate cyclase by forskolin; these processes also include activation of InsP₃ receptors of the sarcoplasmic reticulum of SMCs and some other events. After U73122-induced blocking of phospholipase C and forskolin-induced activation of adenylate cyclase, ATP-caused relaxation can completely be removed by an inhibitor of InsP₃ receptors, 2-APB. This indicates that, under the above conditions, such relaxation is realized exclusively via InsP₃ receptors of the sarcoplasmic reticulum of SMCs. At the same time, ATP-induced relaxation caused by activation of phospholipase C and inactivation of adenylate cyclase is also nearly completely realized with involvement of InsP₃ receptors of the sarcoplasmic reticulum. However, removing the activity of phospholipase C under conditions of blocking of adenylate cyclase and InsP₃ receptors of the sarcoplasmic reticulum in SMCs leads to the recovery of ATP-induced relaxation with the participation of the other intracellular processes. Therefore, two intracellular messengers, phospholipase C and adenylate cyclase, are involved in purinergic inhibition of smooth muscles. Upon their action, multiple intracellular signal pathways are triggered. The level of their participation can be influenced by the initial functional state of intestinal SMCs. These changes are always directed toward the maintenance of normal functioning of the respective organs.